AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 96 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $411,083 | -27.2% | 39,911 | +16.5% | 0.01% | -27.3% |
Q2 2023 | $564,407 | +163.8% | 34,248 | +46.6% | 0.01% | +120.0% |
Q1 2023 | $213,959 | +51.7% | 23,358 | -16.3% | 0.01% | +25.0% |
Q3 2020 | $141,000 | -23.4% | 27,904 | +22.3% | 0.00% | -20.0% |
Q2 2020 | $184,000 | – | 22,814 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |